Molner Company

The Molner Company is a generic pharmaceutical firm headquartered in Royal Oak, Michigan, specializing in the development and commercialization of complex generic drug products. The company focuses on niche therapeutic areas with high barriers to entry, particularly in the fields of ophthalmology and sterile injectables. Molner manages the entire product lifecycle, from initial formulation and regulatory Abbreviated New Drug Application (ANDA) filings to manufacturing and distribution. By utilizing a lean operational model and strategic partnerships, the company provides cost-effective alternatives to high-priced branded medications. Their portfolio includes several FDA-approved ophthalmic solutions and injectable treatments used in clinical and hospital settings.